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Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of 
VHL and p53 
ABSTRACT 
Newcastle disease virus (NDV) is a candidate agent for oncolytic virotherapy. Despite its 
potential, the exact mechanism of its oncolysis is still not known. Recently, we reported that 
NDV exhibited an increased oncolytic activity in hypoxic cancer cells. These types of cells 
negatively affect therapeutic outcome by overexpressing pro-survival genes under the control 
of the hypoxia-inducible factor (HIF). HIF-1 is a heterodimeric transcriptional factor 
consisting of a regulated α (HIF-1α) and a constitutive β subunit (HIF-1β). To investigate the 
effects of NDV infection on HIF-1α in cancer cells, the osteosarcoma (Saos-2), breast 
carcinoma (MCF-7), colon carcinoma (HCT116) and fibrosarcoma (HT1080) cell lines were 
used in the present study. Data obtained showed that a velogenic NDV infection diminished 
hypoxia-induced HIF-1α accumulation, leading to a decreased activation of its downstream 
target gene, carbonic anhydrase 9. This NDV-induced downregulation of HIF-1α occurred 
post-translationally and was partially abrogated by proteasomal inhibition. The process 
appeared to be independent of the tumour suppressor protein p53. These data revealed a 
correlation between NDV infection and HIF-1α downregulation, which highlights NDV as a 
promising agent to eliminate hypoxic cancer cells. 
 
Keyword: Newcastle disease virus; HIF-1α;  Proteasomal; VHL; p53 
 
 
